Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: A register-based cohort study using the us marketscan claims databases

Osteoporosis International

Volumn 23, Issue 12, 2012, Pages 2873-2884

  Pazianas, M ^a   Abrahamsen, B ^b,c   Wang, Y ^d   Russell, R G G ^a,e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d P and G Pharmaceuticals Epidemiology and Health Outcomes   (United States)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Atypical femur fractures; Femoral shaft fractures; Fragility fractures; Low energyfemoral fractures; Medication possession ratio; Oral bisphosphonates; Subtrochanteric fractures

Indexed keywords

ALENDRONIC ACID; IBANDRONIC ACID; RISEDRONIC ACID;

ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FEMUR INTERTROCHANTERIC FRACTURE; FEMUR NECK FRACTURE; FEMUR SHAFT FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; FOLLOW UP; FRAGILITY FRACTURE; HAZARD RATIO; HIP FRACTURE; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT DURATION;

ADMINISTRATION, ORAL; AGED; ALENDRONATE; COHORT STUDIES; DIPHOSPHONATES; DRUG ADMINISTRATION SCHEDULE; ETIDRONIC ACID; FEMALE; FEMORAL FRACTURES; HIP FRACTURES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; UNITED STATES;

EID: 84872072934     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-012-1952-7     Document Type: Article

References (23)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321
2. Pazianas M, Cooper C, Ebetino FH, Russell RG (2010) Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis. Ther Clin Risk Manag 21(6):325-43
3. Wang Z, Bhattacharyya T (2011) Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007. J Bone Miner Res 26(3):553-60. doi:10.1002/jbmr.233
4. Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305(8):783-9
5. Pazianas M, Abrahamsen B (2011) Safety of bisphosphonates. Bone 49(1):103-10, Epub 2011 Jan 12. PubMed PMID: 21236370
6. Shane E, Burr D, Ebeling PR et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 25:2267-2294. doi:10.1002/jbmr.253
7. Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, Reginster JY, Cooper C (2011) Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int 22(2):373-90, Epub 2010 Nov. 18
8. Adamson DM, Chang S, Hansen LG (2008) Health research data for the real world: the Marketscan databases. Thompson Healthcare, New York
9. Dobson AJ, Kuulasmaa K, Eberle E, Scherer J (1991) Confidence intervals for weighted sums of Poisson parameters. Stat Med 10(3):457-62
10. Fisher LD, Lin DY (1999) Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 20:145-57 (Pubitemid 29242575)
11. Andrade SE, Kahler KH, Frech F, Chan KA (2006) Methods: for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15(8):565-74, discussion 575-7 (Pubitemid 44336271)
12. Brankin E, Walker M, Lynch N, Aspray T, Lis Y, Cowell W (2006) The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases. Curr Med Res Opin 22(7):1249-56 (Pubitemid 44085576)
13. Curtis JR, Westfall AO, Cheng H, Lyles K, Saag KG, Delzell E (2008) Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101, 038 new bisphosphonate users. J Bone Miner Res 23(9):1435-41
14. Heinzl H, Kaider A (1997) Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods: Programs Biomed 54(3):201-8 (Pubitemid 27496007)
15. Durrleman S, Simon R (1989) Flexible regression models with cubic splines. Stat Med 8(5):551-61 (Pubitemid 19116001)
16. Heinzl H, Kaider A, Zlabinger G (1996) Assessing interactions of binary time-dependent covariates with time in Cox proportional hazards regression models using cubic spline functions. Stat Med 15:25899-2601
17. Abrahamsen B, Eiken P, Eastell R (2010) Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis. J Clin Endocrinol Metab 95(12):5258-65, Epub 2010 Sep. 15
18. Lefebvre G, Angers JF, Blais L (2006) Estimation of timedependent rate ratios in case-control studies: comparison of two approaches for exposure assessment. Pharmacoepidemiol Drug Saf 15(5):304-16 (Pubitemid 43797118)
19. Kim SY, Schneeweiss S, Katz JN, Levin R, Solomon DH (2011) Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort. J Bone Miner Res 26(5):993-1001. doi:10.1002/jbmr.288
20. Salminen ST, Pihlajamäki HK, Avikainen VJ, Böstman OM (2000) Population based epidemiologic and morphologic study of femoral shaft fractures. Clin Orthop Relat Res 372:241-9 (Pubitemid 30159452)
21. Salminen ST. Femoral shaft fractures in adults: epidemiology, fracture patterns, nonunions, and fatigue fractures. Helsinki University Printing House, Helsinki 2005 ISBN 952-10-2523-9, http://www.doria.fi/bitstream/handle/10024/ 2183/femorals.pdf? sequence01
22. Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM (2009) Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 20(8):1353-62, Epub 2008 Dec. 9
23. Schilcher J, Michaëlsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 364(18):1728-37